Protective Effect of Topical Antibiotics in Breast Augmentation
Zhiyong Lan, Fangfang Lv, Hua Li
openalex +1 more source
Advances in Cytosolic Delivery of Proteins: Approaches, Challenges, and Emerging Technologies
Proteins regulate almost all biological processes, and overcoming the protein's natural membrane inpermeability will provide a unique opportunity for intracellular targeting of related therapeutic proteins. Chemical modification of proteins and different types of delivery vectors can mediate intracellular transport of proteins, providing new ideas for ...
Wenyan Zhang+8 more
wiley +1 more source
The Reverse Dual Plane: A Novel Technique for Endoscopic Transaxillary Breast Augmentation. [PDF]
Ya Z, Xiao L, Zhou L.
europepmc +1 more source
Breast cancer risk in women treated with augmentation mammoplasty (Review)
Alessio Stivala
openalex +2 more sources
ABSTRACT This study investigates the distribution and role of the stem cell marker Troy (Tnfrsf19) in the gastric mucosa of rats during postnatal development and the effects of early weaning. Troy, previously identified as a reserve stem cell marker in adult gastric tissues, is examined across various developmental stages from birth to adulthood.
Isadora Campos Rattes+2 more
wiley +1 more source
Evaluating Access and Outcomes in Gender-affirming Breast Augmentation: A Comparative Study of a County Hospital and an Academic Center. [PDF]
McLaughlin MF+5 more
europepmc +1 more source
Complications after breast augmentation with dermal fillers containing copolyamide: A systematic review. [PDF]
Hedström K, Falk-Delgado A, Sackey H.
europepmc +1 more source
Nothing Dubious or Unpredictable about 24-Hour Recovery in Breast Augmentation
Mark Epstein
openalex +1 more source
The Study of the Safety and Effectiveness of Motiva SmoothSilk Silicone Gel-Filled Breast Implants in Patients Undergoing Primary and Revisional Breast Augmentation: Three-Year Clinical Data. [PDF]
Glicksman C, Wolfe A, McGuire P.
europepmc +1 more source
Abstract This small phase 1C, open‐label, single ascending dose study evaluated the safety, tolerability, and pharmacokinetics (PKs) of DM199, a recombinant form of human tissue kallikrein‐1 (KLK1). A small sample size of both healthy subjects and hypertensive adults recently taking angiotensin‐converting enzyme inhibitors was studied. KLK1 has a known
Michael Giuffre+3 more
wiley +1 more source